Gastroenterology

At this year’s American College of Rheumatology (ACR) 2023 Convergence, held in San Diego, California, USA, between 10th–15th…

A new study suggested that patients with inflammatory bowel disease could have an increased risk of contracting respiratory syncytial virus and may be eligible to receive RSV vaccines.

A systematic review and meta-analysis have indicated 10 interventions that could improve adenoma detection rate (ADR) during screening-related colonoscopies. Read more.

This News Feature explores the impact of anti-TNF biosimilars on global healthcare as a cost-effective solution, enhancing access to treatment options for inflammatory conditions.

This News Feature explores the approaches for optimising anti-TNF therapies in gastroenterology, based on content delivered during UEG…

Despite anti-reflux surgery being recommended for patients with Barrett’s oesophagus in order to decrease the risk of later developing oesophageal adenocarcinoma, recent research suggests that it may be no more effective than anti-reflux medication.

Recent research has shown that alcohol use during the early stages of direct-acting antiviral treatment was not linked to reduced odds for achieving sustained virologic response (SVR) in patients with chronic HCV infection.

This News Feature explores the role of psychological stress in exacerbating inflammatory bowel disease, and offers insights into mind–body care to empower patients.